Methods for treatment of m-TOR inhibitor-associated stomatitis
AssigneeIzun Pharmaceuticals Corp.
InventorsWilliam Z. Levine, Gabriel Jay Nussbaum
Life of this patent
Estimating the term…
Abstract
Embodiments of the invention relate to a method for the treatment of mIAS or prevention of symptoms associated with mIAS in a patient in need thereof comprising administering to a patient in need thereof an amount of a composition comprising extracts of the plant species Sambucus nigra, Echinacea purpurea, and Centella asiatica. Optionally the ratio of Sambucus nigra, Echinacea purpurea and Centella asiatica is about 7:1:2. Further embodiments relate to use of extracts of the plant species Sambucus nigra, Echinacea purpurea, and Centella asiatica for the manufacture of a medicament for the treatment of mIAS or prevention of symptoms associated with mIAS in a patient in need thereof.
Claims13
A method for treating mammalian target of rapamycin (mTOR) inhibitor associated stomatitis (mIAS) in a patient in need thereof, comprising administering an effective amount of a composition comprising Sambucus nigra, Echinacea purpurea, and Centella asiatica extracts to said patient.
Dependencies are inferred from the claim text.